*恭喜浙江省农业科学院俞老师在SCI期刊 Environmental Science and Pollution Research(IF:2.914)上成功发表
*恭喜西安理工大学张老师,环境水利专业,文章成功发表在SCI期刊Environmental Science and Pollution Research上,IF2.914
*恭喜山东交通学院谢老师在SCI期刊APPLIED SURFACE SCIENCE(IF5.15)上成功发表
*恭喜华中科技大学黄老师在SCI期刊 ACS Applied Materials & Interfaces(IF8.456)上成功发表
*恭喜中南大学湘雅医院黄医生在Frontiers in Oncology(IF 4.137)上成功发表
*恭喜复旦大学辛博士在SCI期刊 FEBS LETTERS(IF2.675)上成功发表
*恭喜中南大学陈博士在THIN-WALLED STRUCTURESSCI期刊(IF3.488)上成功发表
*恭喜湖南工学院郭老师在SCI期刊SIMULATION MODELLING PRACTICE AND THEORY(IF2.42)上成功发表
*恭喜东华大学闫老师在SCI期刊Advanced Functional Materials(IF 15.621)上成功发表
*恭喜安徽医科大学肖老师在SCI期刊BMC CELL BIOLOGY(IF 3.485)上成功发表
*恭喜四川大学华西医院谢医生在SCI期刊European Heart Journal: Acute Cardiovascular Care(IF 3.734)上成功发表

0591-83301811

周一~周日, 8:00 - 23:00

13107667616

周一~周日, 8:00 - 23:00

service@editideas.cn

随时欢迎您的来信!

2021年最新SCI期刊影响因子查询系统

期刊名称:
ISSN:
期刊研究方向:
IF范围:
中科院分区:
SCI/SCIE:
是否OA期刊:
排列方式:

VIRCHOWS ARCHIV 期刊详细信息

基本信息
期刊名称 VIRCHOWS ARCHIV
VIRCHOWS ARCHIV
期刊ISSN 0945-6317
期刊官方网站 http://www.springer.com/medicine/pathology/journal/428
是否OA
出版商 Springer Verlag
出版周期 Monthly
始发年份 1994
年文章数 183
最新影响因子 4.535(2021)
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PATHOLOGY 病理学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.52 1.137 0.951
Medicine
Pathology and Forensic Medicine
40 / 184 78%
Biochemistry, Genetics and Molecular Biology
Cell Biology
153 / 265 42%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
204 / 375 45%
补充信息
自引率 4.80%
H-index 90
SCI收录状况 Science Citation Index Science Citation Index Expanded
官方审稿时间
Submission to first decision 28 days
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0945-6317%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/viar
收稿范围
The Official Journal of the European Society of Pathology
Mission statement: To advance the scientific basis of human pathology by the publication (encouragement and dissemination) of high quality research (including molecular and translational studies) and thereby contribute to patient care.
Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息
近期成功发表案例展示